Clinigen Group Plc (CLIGF) 8.7000 $CLIGF Human

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Clinigen Group Plc (CLIGF) 8.7000 $CLIGF

Human Papillomavirus and Cytomegalovirus Therapeutics Market - Global Industry Analysis 2015 for the $2.34 Billion Market
M2 - Mon Apr 20, 8:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8lwwcf/_human) has announced the addition of the "Human Papillomavirus (By Drug Class and Applications) and Cytomegalovirus (By Drug Type and Applications) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global HPV therapeutics market was valued at USD 1,402.3 million in 2012 and is expected to reach USD 2,346.5 million by 2020, growing at a CAGR of 7.7% from 2014 to 2020. Human papillomavirus (HPV) and Cytomegalovirus (CMV) therapeutics market report studies current as well as future prospects of the market on a global scale. The global market for HPV therapeutics is segmented by drug class and applications. Various drug classes applied against HPV infections are immunomodulators, keratolytic agents, anti-neoplastic agents, and sinecatechins. The HPV therapeutics market is studied by application segments which include genital warts, genital cancers, epidermodysplasia verriformis, oral papillomas, and others (oropharyngeal cancer, laryngeal papillomatosis and others). The global HPV therapeutics market has been extensively analyzed on the basis of the effectiveness and sales revenue of major drug classes as well as geographic prevalence of various HPV infections. The global CMV therapeutics market is segmented by drugs and applications. The major drugs prescribed for the treatment of CMV infections are ganciclovir, valganciclovir, foscarnet, and cidofovir. The CMV therapeutics treatment is applied against various CMV infections causing retinitis, pneumonia, gastrointestinal ulcers, encephalitis and others (mouth ulcers, pharyngitis and others). Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global HPV and CMV Therapeutics Market Overview Chapter 4 Global HPV Therapeutics Market Chapter 5 Global Cytomegalovirus Therapeutics Market Chapter 6 Global HPV and CMV Therapeutics Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - AbbVie, Inc. - Actavis plc - Clinigen Group plc - Merck & Co., Inc. - Perrigo Company plc - Roche Holdings AG - Valeant Pharmaceuticals International, Inc. For more information visit http://www.researchandmarkets.com/research/8lwwcf/_human
PRGO: 194.50 (+0.35), MRK: 60.23 (+0.45), ABBV: 65.99 (+0.02), VRX.TO: 270.02 (+2.67)

Clinigen Group plc: Half Year Revenues up 17% to £72.6m, Underlying EBITDA up 8% to £13.5m
Business Wire - Tue Mar 03, 1:08AM CST
Clinigen Group plc (AIM: CLIN, Clinigen or the Group), the global specialty pharmaceuticals and pharmaceutical services business, has today published its half year results for the six months ended 31 December 2014.

Clinigen Group plc Receives FDA's First Ever Drug Shortage Assistance Award
Business Wire - Mon Sep 29, 1:28AM CDT
Clinigen Group plc ('Clinigen' or the 'Group', AIM:CLIN) the global specialty pharmaceutical company, today announces that it has received the first Drug Shortage Assistance Award from the US Food and Drug Administration (FDA) in recognition of its contribution in addressing a US shortage of Foscavir(R) (foscarnet sodium) injection.

Clinigen Group plc: Underlying EBITDA up 19.8% and EPS up 22%
Business Wire - Wed Sep 24, 1:10AM CDT
Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global specialty pharmaceuticals business, has today published its preliminary results for the 12 months ended 30 June 2014.

New Antibiotic VIBATIV(R)a- 1/4 (telavancin) Targets Public Health Priority MRSA Infections for People with Hospital-Acquired Pneumonia Across Europe
PR Newswire Europe - Thu Sep 18, 7:42AM CDT
BURTON-ON-TRENT, England, September 18, 2014 /PRNewswire/ --

Clinigen Group Further Strengthens Oncology Support Portfolio with Acquisition of Ethyol(R) (amifostine), from AstraZeneca
Business Wire - Wed Aug 20, 1:07AM CDT
Clinigen Group plc ('Clinigen' or the 'Group' (LSE: CLIN) (AIM: CLIN) the specialty global pharmaceutical company today announces the acquisition of the global rights to the oncology support therapy, Ethyol(R) (amifostine) from AstraZeneca.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avoid FOGs: Illinois Water's Holiday PSA

Updated Category News Views 86

Don't Ignore the Kitchen Sink This Holiday You ever poured something down the drain and just prayed it wouldn't come back to bite you later? Well, Illinois American Water is throwing up a big, red flag about doing exactly that during the holidays. When we're all busy passing the gravy boat and diving into festive feasts, it's easy to forget the after-party might just turn...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 17

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 0

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Caregiving's Financial Impact on Women: Insights from Cinergy

Updated Category News Views 84

Women Caregivers Face Financial Crossroads When it comes down to it, caregiving is one heck of a responsibility, particularly for women. It's about the sacrifices they make, not just in time but in financial security, too. Step away from a job to care for someone, and it's a dicey game you're playing with future income. The Cost of Generosity: Financial Impacts Cindy...

Continue Reading
iHeartMedia Faces 65% Drop: Fraud Investigation Launched

Updated Category News Views 0

Trouble Tunes for iHeartMedia Investors Alright folks, here's the skinny on iHeartMedia, Inc. These days, it's like everyone's out for a piece of iHeart, and not in the way you'd wanna see—unless you're SBS Law, those shareholder rights hotshots diving into another pond of legal ripples. Seems a heap of head-scratching's going down on their version of transparency with...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 28

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 70

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Alliance for Women in Media Champions Change in 2026

Updated Category News Views 39

A Celebration of Trailblazing Women in Media If there's one thing I've learned about strong leadership, it's that you can't fake authenticity. Today, we're tipping our hats to some genuine trailblazers. The Alliance for Women in Media (AWM) held its annual Gracies Leadership Awards, celebrating the achievements and vision of seven remarkable women. Honoring the...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 51

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights on E Split Corp. Class A Distribution for Shareholders

Updated Category News Views 147

E Split Corp. Class A Distribution Announcement Toronto-based E Split Corp. (TSX: ENS) is thrilled to share important news with its Class A shareholders regarding the upcoming distribution for October. This is a significant update for investors who are keen on dividend payments made by this dynamic fund. Details of the Distribution This distribution signals the company's...

Continue Reading
Aberdeen Investments: Recent Distribution Insights for Shares

Updated Category News Views 187

Understanding Distribution Payments from Aberdeen Investments Aberdeen Investments U.S. Closed-End Funds, including stocks like ASGI, have announced significant updates regarding their distribution payments. These distributions are crucial for investors as they represent a return on their investments. Released on a recent date, the Funds paid these distributions per share...

Continue Reading
Nuvini Group's Impressive 2025 Financial Performance Review

Updated Category News Views 191

Nuvini Group Report Highlights Growth in 2025 Nuvini Group Limited (NASDAQ: NVNI) is making waves with its impressive financial results for the first half of 2025. This Brazilian venture is recognized as a premier acquirer and operator of business-to-business (B2B) software as a service (SaaS) companies. The company has demonstrated a significant increase in cash flow...

Continue Reading
Exciting Housing Announcement: Key Insights for Communities

Updated Category News Views 156

Anticipating New Housing Developments Media outlets are set to cover an important housing announcement with significant implications for local communities. This event highlights the collaboration between government officials and community leaders focused on addressing housing needs and enhancing infrastructure in various regions. Key Officials Present at the Event The...

Continue Reading
Investors Rally Against Edwards Lifesciences After Losses

Updated Category News Views 72

Edwards Lifesciences Faces Investor Backlash Amidst significant financial turmoil, Edwards Lifesciences Corporation (NYSE: EW) is grappling with a class action lawsuit initiated by concerned investors. This situation emerged after the company witnessed a staggering loss exceeding $16 billion in market capitalization. Investors are understandably anxious as they reflect on...

Continue Reading